Podcast

The Cancer Letter's weekly podcast of interviews, discussions, and more to dig deep into the issues that shape oncology.

Tune in every Wednesday for the latest, or tune in for a monthly series, The Directors, which features two directors of cancer centers in conversation about health care policy—and what's keeping them up at night.

The Directors is sponsored by the American Society of Clinical Oncology.

New episodes every Wednesday. Subscribe on Spotify or Apple Podcasts.

Podcast

In The Headlines: Back to “business as usual” at FDA?

The Oncologic Drugs Advisory Committee held its first session since President Trump’s inauguration, with a two-day, back-to-back marathon meeting, signaling a return to business at FDA after significant upheaval at the agency.

May 28, 2025

Vol.51 No.20

Podcast

In The Headlines: Wafik El-Deiry on how “America First” means investing in NCI

Wafik El-Deiry, director of the Legorreta Cancer Center at Brown University, joined The Cancer Letter’s weekly podcast to discuss his recent guest editorial—and confirmed his candidacy for director of the National Cancer Institute.

May 21, 2025

Vol.51 No.19

Podcast The Directors

The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear”

Thomas J. Lynch Jr. and Howard A. “Skip” Burris III lead two institutions that couldn’t be more different—an NCI-designated Comprehensive Cancer Center on one side of the country and a for-profit research enterprise on the other—but they stay up at nights worrying about the same thing.

May 16, 2025

Vol.51 No.19

By Katie Goldberg

Podcast

In the Headlines: “There’s no one to stand up for NCI right now.”

Peer review, registries, and evidence-based patient information have taken a hit in Trump’s first 100 days in office.

May 14, 2025

Vol.51 No.18

Podcast

In the Headlines: Centering patients as cancer research infrastructure is dismantled

The Cancer Letter has covered—and will continue to cover—all the ways in which the current administration is fundamentally reshaping cancer research in the U.S. But this week, The Cancer Letter and the podcast focused on a patient story.

May 07, 2025

Vol.51 No.17

Podcast

In The Headlines: Are cancer registries on the chopping block, and what does it mean if they are?

The National Cancer Registries Program, or NPCR, is a relatively small but highly impactful 33-year-old CDC program that gauges disparities in cancer and tracks progress against the disease. So, why was it left out of the Trump administration’s preliminary budget?

April 30, 2025

Vol.51 No.16

Podcast

In the Headlines: What’s in Trump’s draft budget?

A confidential Trump administration budget document obtained by The Cancer Letter called for a 40% budget cut to NIH and a restructuring of the 27 existing NIH institutes and centers down to just eight. But what else is in it?

April 23, 2025

Vol.51 No.15

Podcast The Directors

The Directors: Louis Weiner and Taofeek Owonikoko on keeping up morale amid uncertainty
“We are resolute. We are committed to continuing to move the work forward.”

Speaking on The Cancer Letter Podcast, Taofeek Kunle Owonikoko recalled recent conversations with two junior faculty members at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center.

April 18, 2025

Vol.51 No.15

By Paul Goldberg

Podcast

In The Headlines: Oncofertility care falls through the cracks, leaving AYA patients behind

Up to 80% of adolescents and young adults with cancer are affected by reduced fertility after treatment—but only 50% received oncofertility counseling and preservation options prior to beginning treatment.

April 16, 2025

Vol.51 No.14

Podcast

In The Headlines: Private funding can’t replace federal funding—but it can help

In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.

April 09, 2025

Vol.51 No.13

Podcast

In The Headlines: Back to “business as usual” at FDA?

In The Headlines: Wafik El-Deiry on how “America First” means investing in NCI

The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear”

In the Headlines: “There’s no one to stand up for NCI right now.”

In the Headlines: Centering patients as cancer research infrastructure is dismantled

In The Headlines: Are cancer registries on the chopping block, and what does it mean if they are?

In the Headlines: What’s in Trump’s draft budget?

The Directors: Louis Weiner and Taofeek Owonikoko on keeping up morale amid uncertainty
“We are resolute. We are committed to continuing to move the work forward.”

In The Headlines: Oncofertility care falls through the cracks, leaving AYA patients behind

In The Headlines: Private funding can’t replace federal funding—but it can help

Renew today!

Subscriber content

Never miss an issue!

Login